Hearing Loss Trial, Recruiting (NCT07646119)

Hearing Loss Trial, Recruiting NCT07646119 Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07646119 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 60 years of age or older
People whose hearing test results show hearing thresholds of 25 dB HL or better across several key sound frequencies in both ears (confirm with trial site)
People who have previously reported having difficulty hearing during an earlier hearing screening
People who are fluent in Mandarin Chinese
People with no history of ear disease, ear injury, medications known to damage hearing, or long-term exposure to loud noise
People with no known neurological or psychiatric conditions, or other serious medical conditions that may affect how the nervous system works

Who may not be able to join:

People who are unlikely to be able to follow the study procedures or complete all required assessments
People who scored below 24 on a standard memory and thinking test (called the Mini-Mental State Examination) during a previous health screening
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+13718339118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07646119

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 86+13718339118

More information: https://clinicaltrials.gov/study/NCT07646119

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 60 years of age or older
People whose hearing test results show hearing thresholds of 25 dB HL or better across several key sound frequencies in both ears (confirm with trial site)
People who have previously reported having difficulty hearing during an earlier hearing screening
People who are fluent in Mandarin Chinese
People with no history of ear disease, ear injury, medications known to damage hearing, or long-term exposure to loud noise
People with no known neurological or psychiatric conditions, or other serious medical conditions that may affect how the nervous system works

Who may not be able to join:

People who are unlikely to be able to follow the study procedures or complete all required assessments
People who scored below 24 on a standard memory and thinking test (called the Mini-Mental State Examination) during a previous health screening
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Registry

ClinicalTrials.gov

Start date

15 June 2026

Est. completion

1 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Conventional pure-tone audiometry (PTA) with extended high-frequency (0.25-16 kHz); Gap Detection Test (GDT); Distortion Product Otoacoustic Emissions (DPOAEs); Electrocochleography; Auditory Brainstem Response (ABR); Frequency-Following Response (FFR); Central neural activity during Memory task measured by fMRI; Central neural activity during listening task measured by fMRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov